Share this article
Share this article
LITTLE SILVER, N.J., March 10, 2021 /PRNewswire/ -- Additive Orthopaedics, LLC., the leader in 3D printed orthopaedic foot and ankle devices, announces the launch of a new educational website focused on the Patient Specific Talus Spacer. The website, www.TotalTalusReplacement.com, contains information about avascular necrosis ("AVN") for patients and surgeons.
(PRNewsfoto/Additive Orthopaedics, LLC.)
Additive Orthopaedics received an approval order in February 2021 from the U.S. Food and Drug Administration ("FDA") for its Humanitarian Device Exemption application for the Patient Specific Talus Spacer for treatment of AVN of the talus. The approval order made the Additive Orthopaedics Patient Specific Talus Spacer the first and only patient specific total talus replacement implant approved by the FDA for use in the United States.